How have the shares performed?
Lixte Biotechnology Holdings Inc. (LIXT) saw an uptrend of 2.25% in the recent trading with $2.73 being its most recent. The current price level -65.27% lower than the highest price of $7.86 marked by the stock while trading over the past 52-weeks, whereas it is 15.68% higher than the lowest price of $2.36 the company dropped to over past 52-weeks. The latest news story on LIXT appeared in ACCESSWIRE under the title “Sidoti Microcap Virtual Conference” on May-18-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -26.22% below one month high and is +10.48% above of the lowest during that time. Looking into the simple moving average, Lixte Biotechnology Holdings Inc. (LIXT)’s stock stands at a SMA-50 of $3.01 while that of 5-day is reading $2.83.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and LIXT’s SMA-200 as of now is $4.50.
Lixte Biotechnology Holdings Inc. Earnings – What Happened With LIXT
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
LIXT – Lixte Biotechnology Holdings Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 12.77 million. LIXT does have institutional investors; and they hold 9.80% of the stock.
Lixte Biotechnology Holdings Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 3 new insider purchases involving 125,001 shares. On the other hand, LIXT declared 0 shares have been sold in 0 insider transactions over the past three months.
As on Dec 30, 2020, Santa Monica Partners LP was the top most holder in Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) with an ownership of 0.17 million shares of the company or 0.25% of the stake worth $0.53 million. The filing also reveals Anson Funds Management LP as the second largest holder in the company with a control over 0.09% of the outstanding shares. Its stake is worth $0.18 million for having 57106.0 shares in hand.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Lixte Biotechnology Holdings Inc. was 23.79 while posting a debt to equity ratio of 0.00.
Technical Analysis of Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Lixte Biotechnology Holdings Inc. (LIXT), we notice that the stock’s 20-day average volume is at 540,085 shares and 100% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 100% are spotting the stock at Sell with its 50-day average volume of 320,452 shares. And to end, LIXT’s 100-day average volume is 788,178 shares with 100% of the long-term indicators pointing towards Sell for the stock.